Posts Tagged ‘RWE’

Saama Technologies and ICON Commercialization and Outcomes Partner to Unlock The Value of Real World Evidence (RWE)

ICON’s Late Phase Experts to Leverage Saama’s Award-Winning Life Science Analytics Cloud to Support Improved Commercial Decision Making   CAMPBELL, CA – (May 15, 2018) – Saama Technologies, a leading clinical and health data analytics company, and ICON plc (NASDAQ: ICLR), a global provider of drug development and commercialization solutions and services, have partnered to…

Read More

Integrating Social Media Data Into Real World Evidence: Value or Distraction?

Real World Evidence

Exploring social media platforms like Facebook, Twitter and LinkedIn, amongst others to collect Real-World Evidence (RWE) is set to take the healthcare industry by storm. Being perceived as a rapid, inexpensive way of assembling vast amounts of data reporting patients’ real experiences of treatment, including drug efficacy, safety and societal impact, is attracting pharma giants…

Read More

Using Real World Evidence to Drive Affordability of Specialty Drugs

life sciences solutions

How can specialty drug manufacturers drive affordability using RWE analytics? Real World Evidence (RWE) is fast becoming a key differentiator in the crowded and competitive pharmaceutical landscape, and more so in the specialty drug segment. RWE refers to the evidence and insights gained from the observation of clinical outcomes in “real world” practice settings. The…

Read More

Webinar: Real World Analytics – Saama Data Science in Action

Harnath Gnana, Sajan Khosla

Date: Wednesday, Feb 25, 2015 Time: 11am PST/2pm EST Speaker: Haranath Gnana & Sajan Khosla Join Saama as we present the perspective on how the Life Sciences and Healthcare industry is dealing with the Real World Evidence challenges. We’ll share some of our Real World Analytics Solution success stories covering how we helped clients leverage…

Read More

Related Posts